Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinguan Lin

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Cell & Bioscience|July 24, 2020
The functions and mechanisms of prefoldin complex and prefoldin-subunitsJiaxin Liang, Longzheng Xia, Linda Oyang, et al.
Frontiers in Oncology|August 8, 2020
Corrigendum: RAC1 Involves in the Radioresistance by Mediating Epithelial-Mesenchymal Transition in Lung CancerShiming Tan, Pin Yi, Heran Wang, et al.
Frontiers in Oncology|May 16, 2020
RAC1 Involves in the Radioresistance by Mediating Epithelial-Mesenchymal Transition in Lung CancerShiming Tan, Pin Yi, Heran Wang, et al.
Oncogene|January 8, 2022
The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activityJinguan Lin, Longzheng Xia, Linda Oyang, et al.
Molecular Cancer|July 31, 2024
Circular RNA hsa_circ_0000467 promotes colorectal cancer progression by promoting eIF4A3-mediated c-Myc translationXianjie Jiang, Mingjing Peng, Qiang Liu, et al.
Frontiers in Oncology|February 9, 2023
The role of tripartite motif-containing 28 in cancer progression and its therapeutic potentialsYiqing Yang, Shiming Tan, Yaqian Han, et al.
Journal of Advanced Research|March 10, 2025
SRSF9 mediates oncogenic RNA splicing of SLC37A4 via liquid-liquid phase separation to promote oral cancer progressionQiu Peng, Lujuan Wang, Ying Long, et al.
Genes & Diseases|June 30, 2025
Fusion genes in cancers: Biogenesis, functions, and therapeutic implicationsHaiqiong Tang, Qiu Peng, Linda Oyang, et al.
International Journal of Biological Sciences|May 19, 2025
Crosstalk between RNA-binding proteins and non-coding RNAs in tumors: molecular mechanisms, and clinical significanceShiwen Cui, Qiu Peng, Qianfeng Ma, et al.
Molecular Cancer|February 6, 2021
The cancer metabolic reprogramming and immune responseLongzheng Xia, Linda Oyang, Jinguan Lin, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Cell & Bioscience|July 24, 2020
The functions and mechanisms of prefoldin complex and prefoldin-subunitsJiaxin Liang, Longzheng Xia, Linda Oyang, et al.
Frontiers in Oncology|August 8, 2020
Corrigendum: RAC1 Involves in the Radioresistance by Mediating Epithelial-Mesenchymal Transition in Lung CancerShiming Tan, Pin Yi, Heran Wang, et al.
Frontiers in Oncology|May 16, 2020
RAC1 Involves in the Radioresistance by Mediating Epithelial-Mesenchymal Transition in Lung CancerShiming Tan, Pin Yi, Heran Wang, et al.
Oncogene|January 8, 2022
The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activityJinguan Lin, Longzheng Xia, Linda Oyang, et al.
Molecular Cancer|July 31, 2024
Circular RNA hsa_circ_0000467 promotes colorectal cancer progression by promoting eIF4A3-mediated c-Myc translationXianjie Jiang, Mingjing Peng, Qiang Liu, et al.
Frontiers in Oncology|February 9, 2023
The role of tripartite motif-containing 28 in cancer progression and its therapeutic potentialsYiqing Yang, Shiming Tan, Yaqian Han, et al.
Journal of Advanced Research|March 10, 2025
SRSF9 mediates oncogenic RNA splicing of SLC37A4 via liquid-liquid phase separation to promote oral cancer progressionQiu Peng, Lujuan Wang, Ying Long, et al.
Genes & Diseases|June 30, 2025
Fusion genes in cancers: Biogenesis, functions, and therapeutic implicationsHaiqiong Tang, Qiu Peng, Linda Oyang, et al.
International Journal of Biological Sciences|May 19, 2025
Crosstalk between RNA-binding proteins and non-coding RNAs in tumors: molecular mechanisms, and clinical significanceShiwen Cui, Qiu Peng, Qianfeng Ma, et al.
Molecular Cancer|February 6, 2021
The cancer metabolic reprogramming and immune responseLongzheng Xia, Linda Oyang, Jinguan Lin, et al.
Pageof 5